We demonstrated that pharmacological and genetic inhibition of HDAC4 largely attenuates renal fibrosis by suppressing several profibrotic signaling pathways, reducing renal injury, and retaining the Klotho expression. The gene discussed is HDAC4; the disease is renal fibrosis.